Evidence map›Paper›PMID 27812771›Full record

ReviewGlycoconjugate journal2017

The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Rana El Masri, Amal Seffouh, Hugues Lortat-Jacob, Romain R Vivès

Abstract readReview
PubMed Publisher
In one paragraph

Review in Glycoconjugate journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rana El MasriUniversity Grenoble Alpes, IBS, F-38044, Grenoble, France.
Amal SeffouhUniversity Grenoble Alpes, IBS, F-38044, Grenoble, France.
Hugues Lortat-JacobUniversity Grenoble Alpes, IBS, F-38044, Grenoble, France.
Romain R VivèsUniversity Grenoble Alpes, IBS, F-38044, Grenoble, France. romain.vives@ibs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological properties of Heparan sulfate (HS) polysaccharides essentially rely on their ability to bind and modulate a multitude of protein ligands. These interactions involve internal oligosaccharide sequences defined by their sulfation patterns. Amongst these, the 6-O-sulfation of HS contributes significantly to the polysaccharide structural diversity and is critically involved in the binding of many proteins. HS 6-O-sulfation is catalyzed by 6-O-sulfotransferases (6OSTs) during biosynthesis, and it is further modified by the post-synthetic action of 6-O-endosulfatases (Sulfs), two enzyme families that remain poorly characterized. The aim of the present review is to summarize the contribution of 6-O-sulfates in HS structure/function relationships and to discuss the present knowledge on the complex mechanisms regulating HS 6-O-sulfation.

Indexed as

AnimalsCarbohydrate ConformationCarbohydrate SequenceCytokinesGlucosamineHeparan SulfateHumansIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsProtein BindingStructure-Activity RelationshipSulfatesSulfotransferasesCytokinesGlucosamineglucosamine 6-O-sulfateHeparan SulfateIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsSulfatesSulfotransferasesBiosynthesisGlycosaminoglycanInteractionStructure/function relationshipsSulfatase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.